- Global Pharma News & Resources

Press Releases - 2023-04-04

Date Title Company
04-Apr-2023 Rocket Pharmaceuticals Announces Leadership Expansion to Support Company on Evolution Towards Commercial Stage Businesswire
04-Apr-2023 Celyad Oncology announces receipt of Nasdaq notice Businesswire
04-Apr-2023 Bioprocess Validation Market is expected to grow at a CAGR of 9.20%, reaching US$ 996.29 million by 2033 | FMI Study MARKITWIRED
04-Apr-2023 Revolutionary At-Home Breast Cancer Screening, Auria®, Debuts at National Consortium of Breast Centers (NCoBC) Annual Conference Businesswire
04-Apr-2023 Ear Health Market is expected to reach a valuation of US$ 3.16 Billion at a CAGR 6.4% by 2033 | FMI Analyst MARKITWIRED
04-Apr-2023 MorphoSys Completes Enrollment of Phase 3 MANIFEST-2 Study of Pelabresib in Myelofibrosis with Topline Results Expected by End of 2023 MorphoSys AG
04-Apr-2023 MaaT Pharma: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital Businesswire
04-Apr-2023 Carpal Tunnel Release Systems Market is expected to reach US$ 863.2 Million at a CAGR of 5.5% by 2029 | FMI MARKITWIRED
04-Apr-2023 Transgene to Host KOL Webinar on TG4050: an Individualized Cancer Vaccine for the Treatment of HPV-Negative Head & Neck Cancers Businesswire
04-Apr-2023 Neuroendocrine Carcinoma Treatment Market is currently dominated by North America | Says FMI Analyst MARKITWIRED
04-Apr-2023 Videojet to Display Latest Coding Solutions for Food Packaging at Food Northwest 2023 Businesswire
04-Apr-2023 Iconex Acquires MAX International Converters, Inc., MAXStick Products Ltd. and Key Assets from McAuliffe Paper Inc. Businesswire
04-Apr-2023 AscellaHealth Recognized for Two Consecutive Years as One of “Americas' Fastest Growing Companies” by The Financial Times Businesswire
04-Apr-2023 Caliber Companies Completes Strategic Growth Investment in Innovative Lab Services Businesswire
04-Apr-2023 Life’s First Naturals® Expands Health Care Practitioner Supplement Line Businesswire
04-Apr-2023 Direct Biologics Announces FDA Authorization to Expand Ongoing Phase 3 Clinical Study of ExoFlo™ to All-Cause Moderate-to-Severe ARDS Businesswire
04-Apr-2023 Brazilian Healthcare Technology Company Secures Sensitive Data With Thales Businesswire
04-Apr-2023 Paragonix Technologies Presenting Expansive Organ Transplant Research at the International Society of Heart and Lung Transplantation 2023 Annual Meeting Businesswire
04-Apr-2023 AIROS Medical Receives FDA Clearance to Market New Peristaltic Pneumatic Compression Device, Truncal Garments for Lymphedema Treatment Businesswire
04-Apr-2023 Transgene to Host KOL Webinar on TG4050: an Individualized Cancer Vaccine for the Treatment of HPV-Negative Head & Neck Cancers Transgene